flucytosine has been researched along with amphotericin b, deoxycholate drug combination in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| de Pauw, BE; Meunier, F | 1 |
| Paterson, DL; Singh, N | 1 |
| Denning, DW; Drusano, GL; Hope, WW; Keevil, B; Louie, A; Reed, P; Sharp, A; Warn, PA | 1 |
| Bicanic, T; Brouwer, AE; Harrison, TS; Macallan, DC; Macsween, KF; Marsh, H | 1 |
| Greenhow, TL; Pahud, BA; Piecuch, B; Weintrub, PS | 1 |
| Aquino, VR; Bay, MB; Falci, DR; Goldani, LZ; Lunardi, LW; Ramos, CG | 1 |
| Celebi, S; Hacimustafaoglu, M | 1 |
| Bekker, LG; Bicanic, T; Harrison, TS; Jarvis, JN; Meintjes, G; Rebe, K; Schutz, C; Williams, A; Williams, GN; Wood, R | 1 |
| Tang, ZH; Yu, YS; Zang, GQ; Zhang, Y | 1 |
| Bicanic, T; Bottomley, C; Brouwer, AE; Harrison, TS; Hosseinipour, MC; Jackson, A; Jarvis, JN; Limmathurotsakul, D; Loyse, A; Meintjes, G; Muzoora, C; Phulusa, J; Taseera, K; van der Horst, C; White, NJ; Wilson, D; Wood, R | 1 |
| Boulware, DR; Merry, M | 1 |
| Eshun-Wilson, I; Ford, N; Garner, P; Migone, C | 1 |
| Chong, Y; Jie, Y; Li, X; Li, Z; Liu, Y; Yan, Y; Zheng, X | 1 |
| Boulware, DR; de Albuquerque Moraes, C; de Oliveira, ACP; de Siqueira, REB; Marcusso, R; Miranda, NFB; Vidal, JE | 1 |
| Alufandika, M; Bicanic, T; Day, JN; Harrison, TS; Hope, W; Jarvis, JN; Lalloo, DG; Loyse, A; Mwandumba, HC; Perfect, JR; Stott, KE | 1 |
| Chang, YJ; Chen, CH; Chen, HM; Chen, YM; Hsu, CW; Li, H; Lin, KH; Lin, PY; Tseng, PT; Tu, YK | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
5 review(s) available for flucytosine and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Fungemia; Histoplasmosis; Humans; Immunocompromised Host; Mycoses; Zygomycosis | 1999 |
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Cryptococcus neoformans; Deoxycholic Acid; Drainage; Drug Combinations; Female; Fluconazole; Flucytosine; HIV-1; Humans; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2005 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross Infection; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units; Leukocyte Count; Mycological Typing Techniques; Neutrophils; Survival Rate; United States | 2011 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningoencephalitis | 2021 |
Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Flucytosine; Humans; Induction Chemotherapy; Meningitis, Cryptococcal; Treatment Outcome | 2021 |
2 trial(s) available for flucytosine and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiviral Agents; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Treatment Outcome | 2012 |
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis.
Topics: Adult; Amphotericin B; Anemia; Antifungal Agents; Blood Cell Count; Coinfection; Creatinine; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; Hemoglobins; HIV; HIV Infections; Humans; Hypokalemia; Induction Chemotherapy; Kidney; Male; Meningitis, Cryptococcal; Neutropenia; Survival Analysis; Treatment Outcome | 2015 |
10 other study(ies) available for flucytosine and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Organ Transplantation | 2002 |
Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Flucytosine; Male; Mice; Microbial Sensitivity Tests; Models, Biological | 2005 |
Preterm neonates with candidal brain microabscesses: a case series.
Topics: Amphotericin B; Antifungal Agents; Brain; Brain Abscess; Candidiasis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echoencephalography; Female; Flucytosine; Follow-Up Studies; Fungemia; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Magnetic Resonance Imaging | 2009 |
Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; HIV Infections; Humans; Infusions, Intravenous; Male; Meningitis, Cryptococcal; Microbial Viability; Middle Aged; Treatment Outcome; Young Adult | 2010 |
Cryptococcal osteomyelitis of the scapula and rib in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Flucytosine; Humans; Middle Aged; Osteomyelitis; Ribs; Scapula; Time Factors; Treatment Outcome | 2012 |
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; United States | 2016 |
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Child; Cryptococcus; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; HIV Infections; Humans; Maintenance Chemotherapy; Meningitis, Cryptococcal; Practice Guidelines as Topic; World Health Organization | 2018 |
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Organ Transplantation; Retrospective Studies; Treatment Outcome | 2019 |
HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Topics: Adult; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Referral and Consultation; Retrospective Studies | 2021 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |